Registration number:
Medshare Ltd
for the Year Ended 31 July 2024
Medshare Ltd
Contents
Company Information |
|
Balance Sheet |
|
Notes to the Unaudited Financial Statements |
Medshare Ltd
Company Information
Directors |
Dr Thomas James Rourke Mrs Jennifer Marion Rourke |
Registered office |
|
Medshare Ltd
(Registration number: 11451772)
Balance Sheet as at 31 July 2024
Note |
2024 |
2023 |
|
Fixed assets |
|||
Tangible assets |
|
|
|
Investment property |
|
|
|
Investments |
|
|
|
|
|
||
Current assets |
|||
Debtors |
|
|
|
Cash at bank and in hand |
|
|
|
|
|
||
Creditors: Amounts falling due within one year |
( |
( |
|
Net current liabilities |
( |
( |
|
Total assets less current liabilities |
|
|
|
Creditors: Amounts falling due after more than one year |
( |
( |
|
Provisions for liabilities |
( |
( |
|
Net assets |
|
|
|
Capital and reserves |
|||
Called up share capital |
|
|
|
Revaluation reserve |
|
|
|
Retained earnings |
( |
( |
|
Shareholders' funds |
|
|
For the financial year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
• |
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.
Approved and authorised by the
Medshare Ltd
(Registration number: 11451772)
Balance Sheet as at 31 July 2024 (continued)
......................................... |
Medshare Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
Tangible assets |
Furniture, fittings and equipment |
Total |
|
Cost or valuation |
||
At 1 August 2023 |
|
|
Additions |
|
|
At 31 July 2024 |
|
|
Depreciation |
||
At 1 August 2023 |
|
|
Charge for the year |
|
|
At 31 July 2024 |
|
|
Carrying amount |
||
At 31 July 2024 |
|
|
At 31 July 2023 |
|
|
Investment properties |
2024 |
|
At 1 August |
|
Additions |
|
Fair value adjustments |
|
At 31 July |
|
The fair value of the properties at the year end have been arrived at on the basis of a valuation carried out at that date by the director of the company, who is not a professionally qualified valuer. The valuations were arrived at by reference to the market evidence of transaction prices for similar properties in the location the properties are situated.
Medshare Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024 (continued)
Investments |
2024 |
2023 |
|
Investments in subsidiaries |
|
|
Investments in associates |
|
|
|
|
Subsidiaries |
£ |
Cost or valuation |
|
At 1 August 2023 |
|
Provision |
|
Carrying amount |
|
At 31 July 2024 |
|
At 31 July 2023 |
|
Associates |
£ |
Cost |
|
At 1 August 2023 |
|
Revaluation |
|
Additions |
|
At 31 July 2024 |
|
Provision |
|
Carrying amount |
|
At 31 July 2024 |
|
At 31 July 2023 |
|
Debtors |
Medshare Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024 (continued)
5 |
Debtors (continued) |
Current |
Note |
2024 |
2023 |
Trade debtors |
|
- |
|
Amounts owed by related parties |
|
- |
|
Prepayments |
|
|
|
Other debtors |
|
|
|
|
|
Creditors |
Creditors: amounts falling due within one year
Note |
2024 |
2023 |
|
Due within one year |
|||
Loans and borrowings |
|
|
|
Trade creditors |
|
|
|
Taxation and social security |
|
- |
|
Other creditors |
|
|
|
|
|
Creditors: amounts falling due after more than one year
Note |
2024 |
2023 |
|
Due after one year |
|||
Loans and borrowings |
|
|
|
Other non-current financial liabilities |
|
|
|
|
|